Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valery Radchenko

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2024
Preclinical Evaluation of <sup>226</sup>Ac as a Theranostic Agent: Imaging, Dosimetry, and TherapyHelena Koniar, Luke Wharton, Aidan Ingham, et al.
Frontiers in Chemistry|February 23, 2024
Exploration of commercial cyclen-based chelators for mercury-197 m/g incorporation into theranostic radiopharmaceuticalsParmissa Randhawa, Imma Carbo-Bague, Patrick R W J Davey, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 26, 2023
Selective Chelation of the Exotic Meitner-Auger Emitter Mercury-197 m/g with Sulfur-Rich Macrocyclic Ligands: Towards the Future of Theranostic RadiopharmaceuticalsParmissa Randhawa, K Lexi Gower-Fry, Cailum M K Stienstra, et al.
Bioconjugate Chemistry|September 20, 2022
H<sub>4</sub>picoopa─Robust Chelate for <sup>225</sup>Ac/<sup>111</sup>In TheranosticsLuke Wharton, María de Guadalupe Jaraquemada-Peláez, Chengcheng Zhang, et al.
Inorganic Chemistry|January 6, 2023
Comparative Study of a Decadentate Acyclic Chelate, HOPO-O<sub>10</sub>, and Its Octadentate Analogue, HOPO-O<sub>8</sub>, for Radiopharmaceutical ApplicationsImma Carbo-Bague, Cen Li, Brooke L McNeil, et al.
Nuclear Medicine and Biology|May 7, 2016
Labeling and preliminary in vivo assessment of niobium-labeled radioactive species: A proof-of-concept studyValery Radchenko, Penelope Bouziotis, Theodoros Tsotakos, et al.
Plos One|December 23, 2017
Separation of 103Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide 103mRhTara Mastren, Valery Radchenko, Philip D Hopkins, et al.
Nuclear Medicine and Biology|February 17, 2015
Evaluation of nitrogen-rich macrocyclic ligands for the chelation of therapeutic bismuth radioisotopesJustin J Wilson, Maryline Ferrier, Valery Radchenko, et al.
EJNMMI Physics|September 14, 2024
Quantitative SPECT imaging of <sup>155</sup>Tb and <sup>161</sup>Tb for preclinical theranostic radiopharmaceutical developmentHelena Koniar, Scott McNeil, Luke Wharton, et al.
Analytica Chimica Acta|November 21, 2017
Chromatographic separation of the theranostic radionuclide <sup>111</sup>Ag from a proton irradiated thorium matrixTara Mastren, Valery Radchenko, Jonathan W Engle, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2024
Preclinical Evaluation of <sup>226</sup>Ac as a Theranostic Agent: Imaging, Dosimetry, and TherapyHelena Koniar, Luke Wharton, Aidan Ingham, et al.
Frontiers in Chemistry|February 23, 2024
Exploration of commercial cyclen-based chelators for mercury-197 m/g incorporation into theranostic radiopharmaceuticalsParmissa Randhawa, Imma Carbo-Bague, Patrick R W J Davey, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 26, 2023
Selective Chelation of the Exotic Meitner-Auger Emitter Mercury-197 m/g with Sulfur-Rich Macrocyclic Ligands: Towards the Future of Theranostic RadiopharmaceuticalsParmissa Randhawa, K Lexi Gower-Fry, Cailum M K Stienstra, et al.
Bioconjugate Chemistry|September 20, 2022
H<sub>4</sub>picoopa─Robust Chelate for <sup>225</sup>Ac/<sup>111</sup>In TheranosticsLuke Wharton, María de Guadalupe Jaraquemada-Peláez, Chengcheng Zhang, et al.
Inorganic Chemistry|January 6, 2023
Comparative Study of a Decadentate Acyclic Chelate, HOPO-O<sub>10</sub>, and Its Octadentate Analogue, HOPO-O<sub>8</sub>, for Radiopharmaceutical ApplicationsImma Carbo-Bague, Cen Li, Brooke L McNeil, et al.
Nuclear Medicine and Biology|May 7, 2016
Labeling and preliminary in vivo assessment of niobium-labeled radioactive species: A proof-of-concept studyValery Radchenko, Penelope Bouziotis, Theodoros Tsotakos, et al.
Plos One|December 23, 2017
Separation of 103Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide 103mRhTara Mastren, Valery Radchenko, Philip D Hopkins, et al.
Nuclear Medicine and Biology|February 17, 2015
Evaluation of nitrogen-rich macrocyclic ligands for the chelation of therapeutic bismuth radioisotopesJustin J Wilson, Maryline Ferrier, Valery Radchenko, et al.
EJNMMI Physics|September 14, 2024
Quantitative SPECT imaging of <sup>155</sup>Tb and <sup>161</sup>Tb for preclinical theranostic radiopharmaceutical developmentHelena Koniar, Scott McNeil, Luke Wharton, et al.
Analytica Chimica Acta|November 21, 2017
Chromatographic separation of the theranostic radionuclide <sup>111</sup>Ag from a proton irradiated thorium matrixTara Mastren, Valery Radchenko, Jonathan W Engle, et al.
Pageof 8